Genetic separation of FK506 susceptibility and drug transport in the yeast Pdr5 ATP-binding cassette multidrug resistance transporter.
暂无分享,去创建一个
[1] C. Higgins,et al. Structure of the Multidrug Resistance P-glycoprotein to 2.5 nm Resolution Determined by Electron Microscopy and Image Analysis* , 1997, The Journal of Biological Chemistry.
[2] K. Yamamoto,et al. Three Amino Acid Substitutions Selectively Disrupt the Activation but Not the Repression Function of the Glucocorticoid Receptor N Terminus* , 1997, The Journal of Biological Chemistry.
[3] André Goffeau,et al. Complete inventory of the yeast ABC proteins , 1997, Nature Genetics.
[4] D. Sanglard,et al. Cloning of Candida albicans genes conferring resistance to azole antifungal agents: characterization of CDR2, a new multidrug ABC transporter gene. , 1997, Microbiology.
[5] D. Clarke,et al. Correction of Defective Protein Kinesis of Human P-glycoprotein Mutants by Substrates and Modulators* , 1997, The Journal of Biological Chemistry.
[6] K. Kuchler,et al. Unusual Protein Secretion and Translocation Pathways in Yeast: Implication of ABC Transporters , 1997 .
[7] M. Kołaczkowski,et al. Anticancer Drugs, Ionophoric Peptides, and Steroids as Substrates of the Yeast Multidrug Transporter Pdr5p* , 1996, The Journal of Biological Chemistry.
[8] D. Clarke,et al. Inhibition of Oxidative Cross-linking between Engineered Cysteine Residues at Positions 332 in Predicted Transmembrane Segments (TM) 6 and 975 in Predicted TM12 of Human P-glycoprotein by Drug Substrates* , 1996, The Journal of Biological Chemistry.
[9] Piet Borst,et al. MDR1 P-Glycoprotein Is a Lipid Translocase of Broad Specificity, While MDR3 P-Glycoprotein Specifically Translocates Phosphatidylcholine , 1996, Cell.
[10] S. Kane. Multidrug Resistance of Cancer Cells , 1996 .
[11] K. Kuchler,et al. The ATP Binding Cassette Transporters Pdr5 and Snq2 of Saccharomyces cerevisiae Can Mediate Transport of Steroids in Vivo* , 1996, The Journal of Biological Chemistry.
[12] D. Sanglard,et al. Susceptibilities of Candida albicans multidrug transporter mutants to various antifungal agents and other metabolic inhibitors , 1996, Antimicrobial agents and chemotherapy.
[13] K. H. Wolfe,et al. Sequence of 29 kb around the PDR10 locus on the right arm of Saccharomyces cerevisiae chromosome XV: Similarity to part of chromosome I , 1996, Yeast.
[14] J. Heitman,et al. Immunosuppressant Target Protein FKBP12 Is Required for P-Glycoprotein Function in Yeast* , 1996, The Journal of Biological Chemistry.
[15] K. Yamamoto,et al. An FK506-sensitive Transporter Selectively Decreases Intracellular Levels and Potency of Steroid Hormones* , 1996, The Journal of Biological Chemistry.
[16] D. Hirata,et al. The Multidrug Resistance-associated Protein (MRP) Subfamily (Yrs1/Yor1) of Saccharomyces cerevisiae Is Important for the Tolerance to a Broad Range of Organic Anions* , 1996, The Journal of Biological Chemistry.
[17] K. Kuchler,et al. The ATP‐binding cassette multidrug transporter Snq2 of Saccharomyces cerevisiae: a novel target for the transcription factors Pdr1 and Pdr3 , 1996, Molecular microbiology.
[18] T. Kwan,et al. Mutagenesis of transmembrane domain 11 of P-glycoprotein by alanine scanning. , 1996, Biochemistry.
[19] M. Gottesman,et al. Altered Drug-stimulated ATPase Activity in Mutants of the Human Multidrug Resistance Protein (*) , 1996, The Journal of Biological Chemistry.
[20] M. Voet,et al. Expression of an ATP-binding cassette transporter-encoding gene (YOR1) is required for oligomycin resistance in Saccharomyces cerevisiae , 1995, Molecular and cellular biology.
[21] K. Kuchler,et al. Mechanisms of resistance to azole antifungal agents in Candida albicans isolates from AIDS patients involve specific multidrug transporters , 1995, Antimicrobial agents and chemotherapy.
[22] K. Kuchler,et al. Endocytosis and vacuolar degradation of the plasma membrane-localized Pdr5 ATP-binding cassette multidrug transporter in Saccharomyces cerevisiae , 1995, Molecular and cellular biology.
[23] Satoshi Omura,et al. Degradation of CFTR by the ubiquitin-proteasome pathway , 1995, Cell.
[24] J. Riordan,et al. Multiple proteolytic systems, including the proteasome, contribute to CFTR processing , 1995, Cell.
[25] D. Clarke,et al. Covalent Modification of Human P-glycoprotein Mutants Containing a Single Cysteine in Either Nucleotide-binding Fold Abolishes Drug-stimulated ATPase Activity (*) , 1995, The Journal of Biological Chemistry.
[26] P. Gros,et al. Functional Dissection of P-glycoprotein Nucleotide-binding Domains in Chimeric and Mutant Proteins , 1995, The Journal of Biological Chemistry.
[27] K. Yamamoto,et al. LEM1, an ATP-binding-cassette transporter, selectively modulates the biological potency of steroid hormones. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[28] L. Greenberger,et al. Functional Evidence That Transmembrane 12 and the Loop between Transmembrane 11 and 12 Form Part of the Drug-binding Domain in P-glycoprotein Encoded by MDR1 (*) , 1995, The Journal of Biological Chemistry.
[29] D. Clarke,et al. Membrane Topology of a Cysteine-less Mutant of Human P-glycoprotein (*) , 1995, The Journal of Biological Chemistry.
[30] I. Pastan,et al. Genetic analysis of the multidrug transporter. , 1995, Annual review of genetics.
[31] K. Kuchler,et al. ATP binding cassette transporters in yeast: From mating to multidrug resistance , 1995 .
[32] Jeffrey A. Lefstin,et al. Influence of a steroid receptor DNA-binding domain on transcriptional regulatory functions. , 1994, Genes & development.
[33] D. Clarke,et al. Mutations to amino acids located in predicted transmembrane segment 6 (TM6) modulate the activity and substrate specificity of human P-glycoprotein. , 1994, Biochemistry.
[34] J. Thorner,et al. A novel FK506- and rapamycin-binding protein (FPR3 gene product) in the yeast Saccharomyces cerevisiae is a proline rotamase localized to the nucleolus , 1994, The Journal of cell biology.
[35] F. Baas,et al. The human multidrug resistance-associated protein MRP is a plasma membrane drug-efflux pump. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[36] A. Goffeau,et al. Genetics and biochemistry of yeast multidrug resistance. , 1994, Biochimica et biophysica acta.
[37] J. Riordan,et al. Cystic fibrosis-type mutational analysis in the ATP-binding cassette transporter signature of human P-glycoprotein MDR1. , 1994, The Journal of biological chemistry.
[38] B. Rost,et al. Combining evolutionary information and neural networks to predict protein secondary structure , 1994, Proteins.
[39] G. A. Scarborough,et al. Direct demonstration of high affinity interactions of immunosuppressant drugs with the drug binding site of the human P-glycoprotein. , 1994, Molecular pharmacology.
[40] A. E. Senior,et al. Covalent inhibitors of P-glycoprotein ATPase activity. , 1994, The Journal of biological chemistry.
[41] D. Clarke,et al. Functional consequences of glycine mutations in the predicted cytoplasmic loops of P-glycoprotein. , 1994, The Journal of biological chemistry.
[42] M. Simonen,et al. Selective retention of secretory proteins in the yeast endoplasmic reticulum by treatment of cells with a reducing agent , 1994, Yeast.
[43] K. Kuchler,et al. Molecular cloning and expression of the Saccharomyces cerevisiae STS1 gene product. A yeast ABC transporter conferring mycotoxin resistance. , 1994, The Journal of biological chemistry.
[44] A. Goffeau,et al. PDR5, a novel yeast multidrug resistance conferring transporter controlled by the transcription regulator PDR1. , 1994, The Journal of biological chemistry.
[45] C. Deber,et al. Transmembrane aromatic amino acid distribution in P-glycoprotein. A functional role in broad substrate specificity. , 1994, Journal of molecular biology.
[46] J. Kunz,et al. Cyclosporin A, FK506 and rapamycin: more than just immunosuppression. , 1993, Trends in biochemical sciences.
[47] B. Rost,et al. Prediction of protein secondary structure at better than 70% accuracy. , 1993, Journal of molecular biology.
[48] J. Thorner,et al. The a-factor transporter (STE6 gene product) and cell polarity in the yeast Saccharomyces cerevisiae , 1993, The Journal of cell biology.
[49] D. Clarke,et al. Functional consequences of proline mutations in the predicted transmembrane domain of P-glycoprotein. , 1993, The Journal of biological chemistry.
[50] D. Clarke,et al. Functional consequences of phenylalanine mutations in the predicted transmembrane domain of P-glycoprotein. , 1993, The Journal of biological chemistry.
[51] A. Duncan,et al. Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line. , 1992, Science.
[52] C. Higgins,et al. ABC transporters: from microorganisms to man. , 1992, Annual review of cell biology.
[53] Matthew P. Anderson,et al. Processing of mutant cystic fibrosis transmembrane conductance regulator is temperature-sensitive , 1992, Nature.
[54] S. Devine,et al. Amino acid substitutions in the sixth transmembrane domain of P-glycoprotein alter multidrug resistance. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[55] J. Sambrook,et al. Protein folding in the cell , 1992, Nature.
[56] P. Gros,et al. A single amino acid substitution strongly modulates the activity and substrate specificity of the mouse mdr1 and mdr3 drug efflux pumps. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[57] S. Kohlwein,et al. Phospholipid synthesis and lipid composition of subcellular membranes in the unicellular eukaryote Saccharomyces cerevisiae , 1991, Journal of bacteriology.
[58] Fred Winston,et al. Methods in Yeast Genetics: A Laboratory Course Manual , 1990 .
[59] M. Azzaria,et al. Discrete mutations introduced in the predicted nucleotide-binding sites of the mdr1 gene abolish its ability to confer multidrug resistance , 1989, Molecular and cellular biology.
[60] R. Sikorski,et al. A system of shuttle vectors and yeast host strains designed for efficient manipulation of DNA in Saccharomyces cerevisiae. , 1989, Genetics.
[61] F. Baas,et al. The human mdr3 gene encodes a novel P‐glycoprotein homologue and gives rise to alternatively spliced mRNAs in liver. , 1987, The EMBO journal.
[62] I. Pastan,et al. Expression of a full-length cDNA for the human "MDR1" gene confers resistance to colchicine, doxorubicin, and vinblastine. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[63] G. Fink,et al. KAR1, a gene required for function of both intranuclear and extranuclear microtubules in yeast , 1987, Cell.
[64] Michael M. Gottesman,et al. Internal duplication and homology with bacterial transport proteins in the mdr1 (P-glycoprotein) gene from multidrug-resistant human cells , 1986, Cell.
[65] D. Eisenberg,et al. Analysis of membrane and surface protein sequences with the hydrophobic moment plot. , 1984, Journal of molecular biology.
[66] G. Fink,et al. Methods in yeast genetics , 1979 .
[67] F. Sanger,et al. DNA sequencing with chain-terminating inhibitors. , 1977, Proceedings of the National Academy of Sciences of the United States of America.